SUSAN DUFFY: Open Payments
NPI 1376617175 · BELLEVUE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,126 in 167 payments from 18 companies in 2025. Trend: 2023 $5,118 · 2024 $3,568 · 2025 $9,126
Food & beverage: $4,023Consulting: $3,600Travel & lodging: $1,404Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 55 | $6,331 |
| ABBVIE INC. | 16 | $480 |
| Janssen Scientific Affairs, LLC | 4 | $394 |
| PFIZER INC. | 19 | $311 |
| Regeneron Healthcare Solutions, Inc. | 9 | $286 |
| Galderma Laboratories, L.P. | 13 | $255 |
| UCB, Inc. | 7 | $172 |
| Novartis Pharmaceuticals Corporation | 16 | $151 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $130 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $112 |
Products named: TREMFYA, CIBINQO, RINVOQ, LIBTAYO, SKYRIZI, NEMLUVIO, Bimzelx, COSENTYX.
Industry payments across WA — which companies pay providers there.
